Valuation (21%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | -0.93 | 28.82 |
| PEG Ratio (TTM) | -0.03 | 1.70 |
| P/S Ratio (TTM) | 0.57 | 2.32 |
| P/B Ratio (TTM) | 2.05 | 2.86 |
| P/FCF Ratio (TTM) | -0.47 | 16.09 |
| Price to 5YR AVG Earnings Ratio | N/A | 9.54 |
| Price to 5YR AVG FCF Ratio | N/A | 45.99 |
Profitability (0%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | -35.32% | 7.06% |
| ROE (TTM) | -164.22% | 12.58% |
| Net Profit Margin (TTM) | -61.08% | 7.96% |
| ROIC 5YR AVG | N/A | 10.93% |
Growth (33%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -17.88% | 194.87% | N/A |
| Revenue | 26.95% | -9.45% | N/A |
| Net Income | -17.60% | 882.89% | N/A |
| Cash Flow | -0.34% | 857.99% | N/A |
Health (11%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 0.93 | 2.35 |
| Quick Ratio (TTM) | 0.89 | 2.29 |
| D/E Ratio (TTM) | 1.32 | 0.31 |
| Interest Coverage (TTM) | -16.32 | 18.51 |
| Piotroski F-Score | N/A | 6 |
| Altman Z-Score | N/A | 4.79 |
| LTL to 5YR AVG FCF | N/A | 5.82 |
| Shares Outstanding Growth 5YR AVG | N/A | 1.48% |